VARIABLES | CMS (n = 90) | CMS + NAs (n = 57) | NAs (n = 132) |
---|---|---|---|
Age (years) | 57 (40 to 69) | 54 (39 to 66) | 67 (48 to 76) * |
Female, n (%) | 32 (35) | 20 (35) | 40 (30) |
SAPS II | 41 (32 to 54) | 44 (30 to 54) | 44 (35 to 55) |
BMI, Kg/m2 | 25 (24 to 25) | 24 (23.7 to 25) | 24 (23 to 27) |
ICU length of stay, (days) | 28 (17 to 38) | 33 (19 to 50) | 15 (8 to 31) * |
Albumin serum level <2 g/dL, n (%) | 14 (15) | 9 (16) | 18 (14) |
Total bilirubin serum level >5 mg/dL n (%) | 7 (8) | 4 (7) | 11 (8) |
NSAID n (%) | 17 (19) | 10 (18) | 43 (33) **** |
ACEI n (%) | 15 (17) | 3 (5) | 16 (12) |
  i.v. iodate contrast n (%) | 35 (39) | 14 (25) | 45 (34) |
Immunocompromised pts n (%) | 13 (14) | 8 (14) *** | 38 (29) * * |
Reason for ICU admission | Â | Â | Â |
  Sepsis, n (%) | 41 (46) | 20 (35) | 56 (43) |
  Neurological injury, n (%) | 4 (4) | 8 (14) | 12 (9) |
  Traumatic injury, n (%) | 31 (34) | 21 (37) | 31 (23) |
  Cardiovascular injury, n (%) | 14 (16) | 8 (14) | 33 (25) |
Comorbidity | Â | Â | Â |
  Hypertension, n (%) | 14 (16) | 12 (21) | 28 (21) |
  Diabetes mellitus, n (%) | 2 (2) | 2 (3.5) | 9 (7) |
  Congestive heart failure, n (%) | 3 (3) | 2 (3.5) | 10 (7.5) |
  Two or more comorbidities, n (%) | 5 (5) | 4 (7) | 16 (12) |
Site of infection | Â | Â | Â |
  VAP, n (%) | 69 (77) | 40 (70) | 91 (69) |
  CVC related-BSI, n (%) | 18 (20) | 13 (23) | 31 (23) |
  Other, n (%) | 3 a (3) | 4b (7) | 10 c (7) |
Complications occurring during ICU stay | Â | Â | Â |
  CRRT, n (%) | 13 (14) | 14 (24) | 29 (22) |
  AKI, n (%) | 31 (34) | 26 (45) | 54 (41) |
  Septic shock, n (%) | 31 (34) | 27 (47) | 70 (53) |
  ICU mortality, n (%) | 31 (34) | 21 (37) | 64 (49) |